Device Trial Radar · NCT02243020
VNS During Rehabilitation for Improved Upper Limb Motor Function After Stroke
Last checked: Nov 20, 2026Latest source record: Sep 15, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
17
Actual
Start
Oct 2014
Primary completion
Dec 2016
Study completion Jun 1, 2022
Sponsor
- Lead sponsor
- MicroTransponder Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 17, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 30 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary study objectives are to assess the safety and feasibility of the therapy, including the surgical intervention and stimulation, as well as to provide information on the appropriateness of the study test measures (assessments) and to provide a basis for sample size calculations for a larger, pivotal study.
Conditions
- Stroke
- Upper Limb Deficits
Interventions
Vagus Nerve Stimulation (VNS)Device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Upper Extremity Fugl-Meyer (UEFM)Time frame: 6-weeks
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
University of Minnesota
Minneapolis, Minnesota
UT Southwestern
Dallas, Texas
UT Houston
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.